Actively Recruiting
Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11
Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2026-03-27
1600
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
Sponsors
F
Fondazione IRCCS Policlinico San Matteo di Pavia
Lead Sponsor
A
ASST Fatebenefratelli Sacco
Collaborating Sponsor
AI-Summary
What this Trial Is About
Enteroviruses are a group of RNA viruses including Coxsackievirus, Echovirus, Poliovirus, and Rhinovirus types. They commonly cause mild illnesses in infants and children but can sometimes lead to serious diseases like liver failure, neurological damage, and heart problems. Recently, severe cases of neonatal Echovirus 11 infection with high fatality rates were reported in several European countries, highlighting the need for better understanding and surveillance of these infections. This research aims to develop and test methods for tracking enterovirus infections in newborns, focusing on Echovirus 11. Activities include screening newborns in intensive care for enterovirus infections, using advanced genetic sequencing to analyze virus strains, and studying viral features that may influence disease severity. The study runs from February 2026 to February 2027 and will collect data to improve detection and understanding of these infections. Participants include neonates admitted to intensive care units whose samples will be tested for enteroviruses. Researchers will estimate infection rates and perform detailed genetic and epidemiological analyses. The study seeks to identify viral variations and host factors linked to severe disease. Sample collection, genomic sequencing, and clinical data analysis are key components. The goal is to enhance knowledge for better diagnosis and management of neonatal enterovirus infections.
CONDITIONS
Brief Title
Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Samples from consecutive neonates admitted to neonatal intensive care unit
You will not qualify if you...
- Insufficient residual samples (volume less than 1 mL of nasal swab) will be excluded from the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - February 2026 to February 2027
Samples are collected from neonates admitted to the neonatal intensive care unit for virological and genomic analysis.
Trial Site Locations
Total: 1 location
1
Fondazione IRCCS Policlinico San Matteo
Pavia, Lombardy, Italy, 27100
Actively Recruiting
Research Team
A
Antonio Piralla
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here